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Abstract
Our understanding of molecular biology of the viruses that infect lagomorphs 
is largely limited to the leporipoxvirus myxoma virus (MYXV) and the lagoviruses 
rabbit haemorrhagic disease virus (RHDV) and European brown hare syndrome 
virus (EBHSV) that infect the European rabbit (Oryctolagus cuniculus) and the 
European brown hare (Lepus europaeus) respectively. Thanks to the great effort of 
historic surveillance studies and careful sample archiving, the molecular evolution 
of these viruses is being resolved. Although historically considered viruses that 
cause species specific diseases recent reports show that several lagomorphs may 
now face the threat of these maladies. The driving factors behind these changes has 
not been determined and the effect of these species jumps on lagomorph popula-
tions has yet to be seen. Lagomorphs are also affected by several other lesser studied 
viral diseases. In addition, recent metagenomic studies have led to the identification 
of novel lagomorph viruses the importance of these to lagomorph health remains to 
be fully determined. In this chapter we summarize molecular aspects of viruses that 
infect lagomorphs, paying particular attention to recent interspecies infections.
Keywords: myxoma virus, rabbit hemorrhagic disease virus, lagomorphs,  
molecular virology, rabbit, hare, species jump
1. Introduction
Two viral diseases affecting Leporidae are listed in the World Organization for 
Animal Health Terrestrial Manual for animals, myxomatosis and rabbit hemor-
rhagic disease. Both are of major significance to wild and domestic rabbits and 
hares causing important environmental harm with significant financial conse-
quences. This is also reflected in the magnitude of scientific literature regarding 
these diseases and the viruses that cause them namely myxoma virus (MYXV) and 
rabbit hemorrhagic disease virus (RHDV). MYXV and RHDV belong to two virus 
families the Poxviridae and Caliciviridae respectively. These virus families include a 
number of other viruses that are of consequence to lagomorphs. In the first section 
of this chapter we consider the molecular biology of viruses from these two virus 
families. Lagomorphs are also subject to a broader range of viral infections that we 
shall outline in part II of the chapter.
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2. Viruses that infect lagomorphs Part I
2.1 Leporipoxvirus (virus family Poxviridae)
2.1.1 A brief history; species jump and evolving virulence
There are currently two leporipoxvirus (virus family Poxviridae) of consequence 
for lagomorphs, myxoma virus (MYXV) and rabbit fibroma virus (RFV). Both 
cause tumorifications in their natural hosts Silvilagus brasiliensis (the Brazilian 
cottontail) and Sylvilagus floridanus (the eastern cottontail rabbit), respectively. 
However, they lead to considerably different outcomes following infection of the 
European rabbit (Oryctolagus cuniculus). RFV may cause myxomas in the European 
rabbit but animals mount an immune response and recover, MYXV however causes 
lethal myxomatosis.
Myxomatosis was first observed by Sanarelli [1] in European rabbits 
(Oryctolagus cuniculus) imported to Uruguay. Local rabbits (Silvilagus brasiliensis) 
(tapeti) were the source of the virus that caused this devastating disease. The 
disease is one of the best studied examples of a virus species jump or cross-species 
transmission. The emergence of myxomatosis in the European rabbit in the broader 
context is directly linked to human activity through deliberate releases of infected 
animals on three continents. The aim was to control populations of rabbits consid-
ered pests in Australia, France and Chile. (reviewed in [2–5]). Seventy years since 
its introduction the disease continues to persist. Through extensive monitoring 
programs and comprehensive virulence studies an evolutionary model of host-
pathogen interactions was developed (reviewed in [5]).
Following the introduction of the disease in Australia attenuated strains of the 
virus soon arose [4] this was accompanied by the selection of more resistant rabbits. 
The comparison of rabbit genomes from before and after the introduction of MYXV 
has given considerable insight into the host resistance mechanism [6]. Immune 
related genes have been identified as being determinant in a complex interplay 
of numerous genes [6]. Based on survival times of laboratory rabbits inoculated 
with different virus isolates Fenner and colleagues defined five virulence grades 
1–5 [4]. Virus isolates of virulence grades 1–2 have over 95% case fatality rates with 
survival times of less than 13 days for grade 1 or up to 16 days for grade 2 virus. 
Rabbits infected with grade 5 virus survive while grades 3 and 4 average survival 
time is 17–29 and 29–50 days respectively. Experimental studies in the decades 
following virus release showed grade 3 viruses to be most common in both Australia 
and Europe. Changes in virus virulence occurred rapidly, with less virulent strains 
detected after one year [4] and a comparison of results from Australia and Europe 
showing a common trend and highlighted the importance of insect vectors and 
weather conditions on selection of virus attenuation [4, 5, 7, 8].
2.1.2 Control and prevention
Myxoma virus (MYXV) is the virus of reference for the Leporipoxvirus genus. 
Poxvirus virions are large with a brick or ovoid shaped morphology (ViralZone). 
Replication occurs in the cytoplasm of infected cells. (reviewed in Fields Virology).
The MYXV genome is a linear double stranded DNA molecule of 161.8 kb 
encoding 171 open reading frames (ORFs). The ends of genome are covalently 
closed forming hairpin terminal loops. The genome of MYXV Lausanne was 
sequenced completely in 1999 by Cameron et al. [9] and contains inverted termi-
nal repeats (ITRs) of 11.5 kb encoding 12 genes which are therefore diploid. The 
MYXV genome contains an abundance of genes with potential immunomodulatory 
3
Viral Disease in Lagomorphs: A Molecular Perspective
DOI: http://dx.doi.org/10.5772/intechopen.98272
functions contained largely in the ITRs while genes the central core of the genome 
are required for virus replication, transcription and morphogenesis (Figure 1). 
Genes found in this central region are highly conserved among the poxviruses [12].
There is no treatment for the disease therefore only preventative measures are 
effective. As the disease is spread most commonly by biting insects (fleas, lice, ticks 
and mosquitos), insect control has fundamental importance, being the first line 
of defence on the farm setting. The introduction of new individuals on to a farm 
or wildlife area should be preceded by quarantine measures and animals showing 
clinical signs should be isolated. However, the only effective measure for virus 
control is currently vaccination.
Several vaccines exist against myxomatosis and these can be divided into two 
types; heterologous and homologous with both types being live attenuated vaccines. 
The heterologous vaccines use RFV (also denominated Shope fibroma virus). RFV 
can be used to provide protection against myxomatosis [13] as it is immunologically 
related to MYXV [14]. However, protection lasts a short time and the heterologous 
vaccines are considered less immunogenic. Heterologous vaccination is often used 
to vaccinate juveniles for the first time whilst subsequent vaccinations are adminis-
tered using homologous vaccines. The homologous vaccines are based on laboratory 
MYXV strains that have been passaged in embryonated eggs or cell cultures until 
an attenuated phenotype is attained [15–17]. Several homologous vaccine strains 
are available in Europe (eg. SG33, MAV, Borgi, Leon162 among others). Protection 
with homologous vaccines offers longer lasting immunity than with the heterolo-
gous vaccines. Myxoma virus causes immunosuppression in rabbits [18] and one 
of the main drawbacks to the use of homologous vaccines may be associated with 
such immunosuppression [18, 19] that could exacerbate underlying subclinical 
infections.
The genome sequences of various vaccine strains have been studied. While there 
is no consensus on individual gene mutations that cause the attenuated phenotype 
in vaccines, several have large regions of the genome absent when compared to the 
parental strains (Figure 1) [11, 20, 21]. For example, the MYXV vaccine strain SG33 
Figure 1. 
Schematic representation of MXYV genome organization. Genes below the black line are designated L and 
those above the line are R. Immunomodulatory proteins of MYXV shown in darker shade of blue [9, 10]. Genes 
colored green indicate homology with California (MSW/ MSD) strains [11]. Genes showing major disruptions 




has a genome 13.5 kbp shorter than Lausanne. The deleted region contained genes 
encoding for M150-M001 proteins (13 genes) including several genes expressing 
immunomodulatory proteins. The region affected contains a large part of the ITR 
and the right end of the central genomic region, while other mutations are also 
present in the genome notably in the open reading frames M011 and M077. SG33 
was derived from a French field isolate and subsequent analysis of the genome 
revealed it to be a recombinant consisting of genomic sequences of the south 
American Lausanne and the Californian MSW/MSD strains [11]. The MAV vac-
cine strain (derived by serial passage of strain MSD isolated during an outbreak 
in California [22] has a 14.2 kbp deletion with respect to Lausanne, affecting both 
terminal regions flanking the ITRs (genes M006L-M009L and M148R-M008L/R). 
Interestingly, one European field strain has been sequenced that also contains a 
large deletion including part of the ITR, isolate Munich-1, this strain is described 
as virulent. Therefore, the precise mechanisms of attenuation of vaccine strains 
remain undefined however, the role of the large deletions that include genes 
involved in immunoregulation seems evident.
The publication of the MYXV genome coupled with advances in recombinant 
DNA technology and in vitro poxvirus manipulations paved the way for the design 
of recombinant attenuated strains and the development of potentially safer vaccines 
and may offer the possibility of reducing immunosuppressive effects. The deletion 
of virulence factors and the development of viruses with attenuated phenotypes 
[23, 24] has provided key information for the possible development of recombinant 
vaccines based on targeted attenuation.
Novel recombinant bivalent vaccines have been developed using MYXV as 
a vaccine vector that enable simultaneous vaccination against MYXV and other 
pathogens in domestic [25, 26] and potentially wild rabbits [27, 28]. The Spanish 
field strain 6918 showed great promise as a potential vaccine candidate in wild 
rabbits. A field trail of this vaccine showed that 50% of contact rabbits generated 
antibodies over a 32-day period. This isolate has also been used as a vector to express 
the capsid protein of rabbit haemorrhagic disease virus. The potential use of MYXV 
as a vaccine vector is not limited to use in rabbits. Indeed vectors have been tested 
in different species [29–31] including humans for use as an oncolytic virus vector 
(reviewed in [32]).
Outbreaks of myxomatosis still occur in farmed rabbits although efficient vac-
cines have been available since the 1980s. One major problem is that field strains are 
endemic in feral rabbit populations. There is therefore a constant source for virus 
introduction onto farms through uncontrolled insect vectors. Such outbreaks lead to 
doubts over the efficacy of current vaccines and the causes of these vaccine breaks 
have been investigated. Sequence data of field strains causing farm outbreaks show 
that the virus has not changed sufficiently to render vaccines outdated, indeed 
under laboratory conditions a traditional vaccine strain proved protective if the 
vaccinated rabbit generated antibodies [33]. However, the route of administra-
tion appeared to be a crucial factor. In this study a group of animals vaccinated 
subcutaneously failed to seroconvert and were susceptible to fatal infection, while 
animals vaccinated intradermically showed seroconversion and were protected. The 
key to controlling such phenomena on the farm setting is surveillance of antibody 
response following vaccination.
The two strains of the virus initially released in Europe and Australia have been 
completely sequenced. The reference strain (isolated in Brazil in 1949) known as 
Lausanne was released in Europe, while the Standard Laboratory Strain (SLS) also 
termed Moses strain was isolated in Brazil in 1910 and maintained by passage prior 
to its release in Australia (Moses 1911, reviewed in [5]). The fact that the date, loca-
tions, and viral sequence of released strains are known allows for the comparative 
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study of past and present MYXV sequences. Such precise data is unique and have 
allowed for continental scale virus evolution studies [21, 34, 35]. These studies have 
demonstrated that MYXV showed high mutation rates, frequent loss of ORFs due 
to nucleotide insertions or and deletions [21, 34, 35]. The evolution of complete 
genome sequences of MYXV strains over more than 70 years coupled with the data 
on virulence and virus phenotypes provided by disease monitoring programs [4] 
provide a powerful tool for the detailed analysis of the molecular mechanisms of 
virulence and attenuation. In addition, the study of recombinant knockout viruses, 
viruses with individual genes removed under laboratory conditions, and subse-
quent analysis of changes in virulence associated with gene knockouts allows the 
determination of these mechanisms with much greater precision (reviewed in [21]). 
Understanding the molecular mechanisms of attenuation will be crucial for the 
design of better control measures of MYXV.
2.1.3 Molecular mechanism of attenuation
Phenotypic studies of MYXV isolates demonstrated the emergence of attenuated 
field strains. Analysis of sequences of attenuated strains has revealed that virus 
attenuation is multifactorial. Such studies reveal there are varied pathways to the 
evolution of attenuation [2, 35]. Several genes have been shown to be involved but 
no single common mutation or group of mutations account for similar virus phe-
notypes. Genome wide analysis of MXYV strains isolated between 1952 and 1999 
demonstrated the broad range of genes involved in MYXV evolution [34]. Strains of 
known virulence grades were included in such studies and although viruses shared 
virulence grades no common mutations between them were observed [34, 36] 
with similar results being obtained for Australian and European isolates [35, 36]. A 
subsequent study of isolates obtained between 2000 and 2021, (following the emer-
gence of RHDV) showed a drastic change in virus evolution, echoing the effects 
that RHDV had on rabbit populations and highlighting the adaptability of MYXV 
to persist in the face of ever changing circumstances [37]. A more pronounced virus 
evolution was detected but once again the complexity behind attenuation/virulence 
were noted [37] as were the effects of RHDV and climatic conditions on the evolu-
tion of spread and transmission [37, 38].
The complexity behind the molecular explanation of attenuation is further 
exacerbated with the knowledge that individual or combination gene knockout 
studies have not precisely replicated attenuation in recombinant strains [39]. For 
example, of the Australian attenuated isolates, Uriarra contains an indel disrupting 
the M005L/R gene, while Meby codes for a truncated M153R gene. Both genes prod-
ucts play roles in immunomodulation [40, 41] and recombinant viruses with these 
genes deleted are less virulent (M005 highly attenuated, M153 moderately, [40, 42] 
respectively). However, reversion studies (replacing defective genes with corrected 
homologs in the genetic background of the parental attenuated strain) failed to 
show differences in the virus phenotype. The role of additional subtle mutations 
occurring in other parts of the virus genome although more difficult to decipher 
may hold the key to understanding attenuation completely. In the case of European 
isolates, attenuated strains have also been identified, e.g. Nottingham4-55/1 and the 
Spanish isolate 6918. Nottingham4-55/1 contains a truncated M150R gene. M150R 
(also termed myxoma nuclear factor (MNF)) is an immunoregulatory/host range 
protein [43] and one of the poxviral ankyrin-repeat (ANK-R) protein superfamily 
members. Recombinant virus with an MNF deletion is attenuated [44]. In addition 
to being attenuated, the Spanish isolate 6918 was poorly transmitted to contact rab-
bits demonstrating an additional phenotypic characteristic making it a possible safe 
vaccine candidate for use in wild rabbits [27, 28, 45]. Genome sequencing of isolate 
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6918 revealed mutations in four genes (M009L, M036L, M135R and M148R) leading 
to potential truncation of expressed proteins [46] (Figure 1). The M135R and 
M148R genes are likely candidates to affect virulence, while mutations in M009L 
and M036L genes have also been detected in virulent MYXV strains [47] however, 
the precise relation of these genes with attenuation has yet to be demonstrated. To 
date reversion studies using European strains have not been documented.
2.1.4 Diagnosis
In Europe the disease had a profound effect on rabbit populations including 
extinctions at local levels [48, 49] and much wider ranging ecological effects  
[49, 50] especially in the Mediterranean basin where the rabbit is considered a 
keystone species [51, 52]. Surviving rabbits show immunity [53] therefore disease 
maintenance requires sufficient susceptible naive juvenile rabbits and outbreaks 
therefore occur in temporal peaks which are also dependent on the availability of 
insect vectors which help to spread the virus (reviewed in [5]). In addition to the 
ecological effect, the rabbit industry (meat and fur) suffers substantial economic 
losses each year due to rabbit deaths and costs of control measures [54, 55].
Initial diagnosis may be based on the characteristic symptoms presented, how-
ever, disease caused by attenuated or respiratory strains maybe mistaken for bacte-
rial infections. Laboratory diagnosis is therefore important and several methods 
are available for this task (reviewed in [56, 57]). Isolation of the virus in susceptible 
cell cultures (e.g. RK13 rabbit kidney cells) gives characteristic cytopathic effect but 
requires several days for confirmation and is therefore accompanied by serological 
or molecular techniques such as the detection of virus genome by PCR [20]. The 
most common samples for virus detection are tissue (eyelid, skin lesions, lung etc), 
swabs (conjunctival or genital) and sera for antibody detection. These techniques 
maybe complemented by electron microscopy, histology, agar gel immunodiffu-
sion, fluorescent antibody test among others [57]. Detection of the virus genome 
requires extraction of viral DNA and subsequent PCR analysis and confirmation 
by sequencing may also be used. Targeted regions vary and include M153R [58] and 
M135R [59] or M005L/R gene within the TIRs (and therefore diploid) for qPCR 
[60] or conserved genes such as M022L [61] or M071L [20, 57] for conventional 
PCR analysis. Such analyses serve to confirm the presence of MYXV DNA, however, 
additional analysis of more regions are required to distinguish wildtype from vac-
cine strains [20] or in the absence of genome sequencing, to generate information 
regarding phylogeny [62, 63]. TIR regions in poxvirus genomes have been shown 
to be more variable [64], and RFLP analysis of long range PCR-amplified TIR 
regions from MYXV positive samples also allows for the molecular differentiation 
of strains [65].
Serological tests exist for the detection of anti-myxoma virus antibodies  
[19, 66, 67]. This analysis is of particular importance in farmed rabbits where 
vaccination is used.
2.1.5 MYXV jumps species to the Iberian hare (Lepus granatensis)
Myxoma virus is traditionally termed as being specific to the European rabbit. 
Soon after its release in Europe however, isolated cases were described in hare spe-
cies (reviewed in [4]). More recently myxomatosis has been described in hares in 
the UK [68]. Experimental infections of hares (Lepus europaeus) with MYXV failed 
to result in disease [4] and natural cases seem to have been sporadic as no large-scale 
infections were described. These results do, however, demonstrate the susceptibility 
of hare species to MYXV infection, at least in certain circumstances. In spring 2018 
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the situation changed dramatically with reports of widespread infections in the 
Iberian hare (Lepus granitensis) occurring on the Iberian Peninsula [69–71]. Over 
300 cases were reported and confirmed as positive for MYXV thus being the first 
large scale infection of hares with MYXV. The outbreak continued and spread over 
the Iberian Peninsula throughout 2018–2020 [72]. The impact this virus will have on 
the Iberian hare population has yet to be seen and must be continually monitored so 
that suitable control measures can be adopted. The virus has also been detected in 
wild rabbits (Oryctolagus cuniculus algirus) and commercial rabbits highlighting the 
need for control and monitoring [73].
Genomic analysis of the MYXV infecting the Iberian hare population showed 
the genome to contain an additional 2,8 kbp with regards to the reference strain 
Lausanne (Figure 1). How MYXV gained this genomic region is unknown, but 
homologous recombination has been demonstrated as a frequently occurring 
mechanism for poxviruses to gain selective advantage through the acquisition of 
genetic material from coinfecting viruses [74–76]. The genomic region present in 
the hare- infecting MYXV contained 4 full open reading frames which showed 
homology to MYXV genes M060R, M061R, M064R and M065R. The homologous 
region within the MYXV genome contains 6 genes, M060R-M065R, therefore 
homologs to M062 and M063 are missing from the hare specific genomic region. 
The nature of the ORFs included in the insertion led to two possible explanations: 
a duplication event of genes M060-M065 had occurred with the subsequent loss of 
ORFs M062 and M063 [70], or the capture by homologous recombination of this 
region from an as yet unidentified poxvirus [70, 71]. The exact cause of the species 
jump has yet to be explained, although the determination of the function of the 
gene products from within this region is sure to shed light on this phenomenon.
3. Lagovirus (family Caliciviridae)
There are two devastating diseases caused by lagoviruses that effect lagomorphs. 
Rabbit haemorrhagic disease (RHD) and European Brown Hare Syndrome (EBHS), 
as the names suggest, both were considered species specific. However, recent find-
ings require that this view be revised. Both diseases have been endemic in Europe 
since the first descriptions in the 1980s (reviewed in [77, 78]). Due to the economic 
and ecological importance of the European rabbit, RHD has been the subject of 
most research. But the recent emergence of a lagovirus with broader host range, 
associated ecological concerns and advances in the molecular biological tools avail-
able for the study of these diseases, is changing this dynamic.
3.1 Rabbit haemorrhagic disease virus (RHDV)
3.1.1 RHDV GI.1
Rabbit haemorrhagic disease first came to light in China in 1984 in angora rab-
bits imported from Europe in what appeared to be the emergence of a novel highly 
virulent disease that rapidly killed thousands of domestic rabbits. The disease 
spread throughout China and Korea and reached Europe (Italy) in 1986 (reviewed 
in [77, 79]).
The first report of cases in Spain, the native home of the European rabbit was 
in 1988 [80] in domestic rabbits and the disease soon caused epizootic episodes in 
wild rabbits [81]. The reduction of the wild rabbit population was severe [82] and 
this had direct effects on specialist predator species such as the endangered Iberian 
lynx (Lynx pardinus) or Spanish Imperial Eagle (A. adalberti) [52, 83]. Such were 
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the effects of the disease on rabbit populations in Europe that tests were carried out 
for the use of the disease as an additional biocontrol measure against the rabbit pest 
in Australia, which was recovering following the initial success of myxomatosis in 
control efforts [84].
RHDV, the etiological agent of RHD, remained endemic in Europe for more than 
30 years with a single serotype (RHDV GI.1) prevalent until 2010. Rabbits that sur-
vive infection generate a strong long lasting immunity with detectable anti-RHDV 
antibodies in sera. Young rabbits are not susceptible to the disease caused by RHDV 
GI.1, however, they may be infected and the mechanism of resistance is not fully 
understood. The economic effects of the disease in the rabbit farming sector are 
considerable. Inactivated vaccines (e.g. RHDV infected liver homogenates treated 
with β-propiolactone) were developed [85, 86] and proved successful in stemming 
mortalities in commercial rabbitries although due to the natural reservoir of RHDV 
in wild rabbits, control measures must be consistently maintained. With regards 
to control it is important to indicate that direct contact between rabbits [87] and 
fomites (contaminated food and bedding) play an important role in farm outbreaks. 
In natural infections, the faecal-oral route is considered the preferential mode of 
virus transmission [88] reviewed in [78]). In the wild, rabbit carcasses are also a 
major virus source with spread being facilitated by predators and carrion feeding 
insects [89, 90].
3.1.2 RHDV GI.2
In 2010 atypical outbreaks of RHD were detected. The virus responsible for 
these outbreaks was initially recognized in France [91] and termed a new variant of 
RHDV, where outbreaks affecting vaccinated rabbits caused concern. The variant 
was later detected in Spain, where isolates of the virus were used to show suscep-
tibility of young rabbits, demonstrate major antigenic differences with regards to 
RHDV GI.1 and the presence of virus in the intestine [92]. Another considerable 
difference with the disease caused by this virus when compared to classic RHDV 
GI.1 is the level of mortality. RHDV GI.1 typically shows mortality rates of 80–90% 
in adult rabbits [93] with no mortality in kits, while the variant RHDV showed 
approximately 10% in adult rabbits and up to 50% in kits. The terms variant and 
RHDVb were first used to identify this virus [91, 92]. Subsequent publications used 
the terms RHDVb and RHDV2. In order to avoid confusion and bring order to the 
nomenclature system for the lagoviruses, Le Pendu et al., put forward a new scheme 
where by RHDVb/RHDV2 was termed Lagovirus europaeus/GI.2/ (GI.2), and RHDV 
was termed Lagovirus europaeus/GI.1/, (GI.1). The proposed nomenclature and clas-
sification system allows systematic definition using phylogeny and genetic distances 
to define isolates, includes pathogenic and non-pathogenic lagoviruses and allows 
for the incorporation of as yet unidentified virus sequences [94].
Given the novel characteristics of RHDV GI.2 it was unsurprising that the virus 
continued to spread. By 2013, the virus had been detected throughout France, 
Spain, Portugal and was present in Italy [95–97]. RHDV GI.2 and has since spread to 
pandemic proportions and has been detected on the continents of Europe, Africa, 
Asia, Australia and North America.
The lack of full cross protection induced by previous contact with RHDV GI.1 
strains contributed to the rapid spread of RHDVGI.2 in Europe [98, 99], resulting 
in high mortality rates among wild populations soon after its emergence. Therefore, 
vaccines based on RHDVGI.2 containing inactivated liver extracts have been 
produced to aid in control of the disease in domestic rabbits.
The observation of partial protection between GI.1 and GI.2 was supported 
by data from RHDV GI.2 infections in Australia where mortality was detected in 
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RHDV domestic vaccinated animals [100] and contributed to its rapid spread in the 
wild [101]. Currently, it appears as though RHDV GI.2 has become the predominant 
RHDV on the Iberian Peninsula [102, 103], and also on mainland Australia replac-
ing endemic strains of RHDV GI.1 [100]. While this may lead to environmental and 
economic benefits in Australia [104] the establishment of this virus in Europe poses 
an important problem for the conservation of the European rabbit, particularly in 
smaller populations [105, 106] and for the preservation of reliant predators [107].
3.2 Rabbit calicivirus (RCV) GI.3 and GI.4
The presence of anti-RHDV antibodies in rabbit populations is indicative of cir-
culation of RHDV. However, in 1995, antibodies reactive with RHDV were detected 
in rabbits that showed no clinical signs of RHDV infection [108]. This finding was 
substantiated by the identification of a non-pathogenic calicivirus (termed rabbit 
calicivirus - RCV) [109]. RCVs were subsequently detected in Australia [110] and 
France [111]. RCV lagoviruses, are genetically related to RHDV although they dem-
onstrate different cell tropism and are apathogenic. While RHDV target organs are 
lung, liver and spleen, RCV was found predominantly in the intestine. The presence 
of RCV has been argued as having a protective effect on rabbit populations facing 
RHDV outbreaks and may have been a determining factor in the speed of spread 
of RHDV in Europe and Australia [112], however the levels of protection vary and 
are likely dependent on differing levels of cross reactive and timing of infections 
[111, 113].
3.3  European brown hare syndrome virus (EBHSV) GII.1 and Hare calicivirus 
(HaCV) GII.2
European Brown Hare Syndrome Virus (EBHSV) GII.1 has been detected in many 
European countries and Argentina having emerged in Sweden in the early 1980s 
and Denmark in 1982 (reviewed in [114–121], although retrospective studies have 
demonstrated that the virus was present before this time [122, 123]. EBHSV causes 
disease in brown hares (Lepus europaeus) and mountain hares (Lepus timidus) [114, 
124], while the eastern cottontail (Sylvilagus floridanus) is also susceptible [125] but 
not the European rabbit (Orytolagus cuniculus) [126]. The disease symptoms are 
similar to those observed for RHDV, most notably the disease is acute and may show 
respiratory and nervous symptoms and epistaxis [127], the liver shows severe nec-
rotizing hepatitis although differences between the diseases have also been reported 
[128]. Similar to RHDV GI.1, EBHSV does not infect young hares [121, 124].
The identification of hare caliciviruses (HaCV) GII.2 related to EBHSV have 
further shown the large diversity and complexity that exists for this genera of virus 
[129–132]. HaCV has been detected in duodenum or faeces of healthy hares in Italy, 
France, Austria, Germany and Australia (also weakly detected in liver) [129–133]. 
The virus is considered to be non-pathogenic based the health status of animals 
from which the samples were obtained and the target organ, however, virulence 
phenotypes have not been published. Expanding our knowledge on these viruses 
will undoubtedly help decipher their role in protecting populations of lagomorphs 
from pathogenic viruses and in the emergence of novel viruses through recombina-
tion events.
As lagoviruses EBHSV and HaCV have the same genome organisations  
(Figure 4) and virion morphologies as RHDV, however they form separate genetic 
groups following phylogenetic analysis and are antigenically different from RHDV 
[123, 134–137]. RHDV GI.2 has also been detected as highly virulent in different 
hare species [138] either as a result of spill-overs from closest rabbit populations or 
Lagomorpha Characteristics
10
from hare to hare transmission. These findings have highlighted the need for studies 
into virus cross species infections in lagomorphs [130, 132]. Recent detection of 
RHDV GI.2 and EBHSV GII.1 recombinant viruses [139] highlight the capacity for 
evolution of the lagoviruses and indicate the importance of continued vigilance in 
order to protect vulnerable lagomorph species.
3.4 Virion, genome organization
Lagoviruses are non-enveloped icosahedral single-stranded positive-sense RNA 
viruses [87, 140, 141]. As well as the morphological features of virions all lagovi-
ruses share a common genome organisation, have conserved genomic features and 
express two ORFs as shown in Figure 2.
ORF 1 expresses a polyprotein that is processed to form non-structural 
mature peptides and VP60 the major structural capsid protein (also termed VP1 
in the literature). ORF 2 encodes VP10 a minor structural protein, also termed 
VP2. Lagoviruses also share conserved polyprotein processing sites (Figure 3) 
and. Transcribe a VPg-linked subgenomic RNA from which VP60 and VP10 are 
expressed. The ORFs for VP60 and VP10 overlap and expression of VP10 occurs via 
a termination/reinitiation mechanism (Figure 3).
RHDV GI.1 is the lagovirus that has been most extensively characterised and is 
therefore the virus of reference for this genus. The virus genome is approximately 
7.4 kb in length. Viral particles are small (35–40 nm diameter) and contain genomic 
(gRNA) and subgenomic RNA (sgRNA) which is collinear with the 3′ end of the 
genomic RNA [143–145]. Both RNAs are polyadenylated at the 3′ end. At their 5′ 
region they are covalently linked to the VPg (virus genome-linked) protein [146] 
(Figure 2) which may act as a substitute for cap during RHDV translation [147]. 
Genomic RNA contains two open reading frames (ORFs): ORF1 codes for a polypro-
tein of 257 kDa, which after a post-translational cleavage by a viral protease results 
in 7 non-structural proteins (p16, p23, p37 (NTPase), p29, p13 (VPg), p15 (protease), 
Figure 2. 
Schematic representation of a lagovirus genome and the main genomic features shared amoung the lagoviruses. 
Fragments of sequence alignments from indicated isolates show: 5′ nontranslated region (NTR), polyprotein 
translation start site, subgenomic RNA initiation sites, termination upstream ribosomal binding site (TURBS) 
core sequence and termination/reinitiation site required for VP10 translation [142].
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p58 (RNA-dependent RNA polymerase) (also termed non-structural proteins (NS) 
1–7) and the major capsid protein (VP60) [144, 145, 148]. The RNA sequences 
encoding ORF1 and ORF2 overlap by 20 nucleotides. The reading frame of ORF2 is 
shifted with respect to ORF1 and codes for the minor capsid protein (VP10) which is 
10–12 kDa. VP10 (also termed VP2 in some publications in accordance with noro-
virus nomenclature) is translated by a termination/reinitiation mechanism [142], 
dependent on a TURBS (termination upstream ribosome-binding site) element 
(core sequence GUGGGA) located within the VP60 coding sequence [149]. The role 
of VP10 protein has been linked with viral replication regulation and promotion of 
apoptosis for the liberation of virions from infected cells [145, 150]. The biological 
role of non-structural proteins has been studied by sequence analysis and functional 
studies, as well as being based on previous knowledge gathered from members of the 
Picornaviridae family [143, 145, 151]. Four of the nonstructural proteins have well 
defined functions, namely the RNA helicase (p37) [151], the virus genome linked 
protein VPg (p13), 3C-like protease (p15 or Pro) and the RNA-dependent RNA poly-
merase (RdRp) [146, 152, 153] (Figure 3). RdRp has been shown to catalyze VPg uri-
dylation [146, 154]. The RHDV protease (Pro) [155] catalytic site has been mapped 
by site directed mutagenesis [155] and the target viral peptides have been identified 
[156]. The RdRp functions in replicating the viral RNA and VPg uridylation [154]. 
While the precursor (Pro-Pol) shows activity, the processed mature form shows 
increased capacity in polymerase function [154]. Expression of recombinant RHDV 
RdRp in transfected RK13 cells leads to Golgi membrane reorganization [157]. The 
crystal structure of this protein has been elucidated [158] allowing insights into the 
structural-functional mechanism involved in virus replication. The intracellular 
location of the RHDV non-structural proteins p16, p23 and p29 have been recently 
determined [157], however, their functions are still unknown.
3.5 VP60 major structural virion component
By far the most well characterized of the RHDV proteins is VP60. It is the 
major structural component of virions, responsible for receptor binding, is highly 
Figure 3. 
Schematic representation of conserved motifs located in the ORF 1 encoded polyprotein and amino acid 
alignments showing conserved proteolytic processing sites among lagoviruses.
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immunogenic and the target of neutralizing antibodies. VP60 is expressed from 
subgenomic RNA in infected cells facilitating sufficient levels for virion assembly. 
High levels of sgRNA make it a good target for diagnostic RT-PCRs and its variabil-
ity due to immune selection befit subsequent sequence analysis. Sequence data from 
partial and full-length fragments of VP60 encoding RNA have been the basis for 
comparative sequence analysis.
Although RHDV is not cultivatable in vitro the expression of VP60 and the 
formation of virus-like particles (VLPs) makes recombinant vaccine production an 
attractive alternative and ethically acceptable substitute for traditional inactivated 
vaccines which are prepared from infected liver homogenates.
VLPs have been used to characterize this protein structurally, determine its 
antigenicity and study receptor binding [159–164]. Additionally, purified wildtype 
virus particles have been used to determine an atomic model by cryo-electron 
microscopy [165].
RHDV GI.2 isolates are antigenically distinct from RHDV GI.1 and agglutinate 
human erythrocytes, to differing degrees, [92, 166–168]. Hemagglutination is 
dependent on the presence of ABH blood group antigens and these molecules have 
been proposed as receptor components of the binding pathway [169]. Indeed, the 
species specific nature of these molecules may explain susceptibility to different 
lagoviruses [170].
Virions are composed of 90 dimers of VP60 which form 32 cup-shaped depres-
sions on the surface of virions (from which comes the name Calici- from the latin 
calix or cup) [165, 171]. Each monomer of VP60 consists of a shell (S) domain, 
which is buried inside the virion structure, and flanked by the N-terminal arm 
(NTA) and the so-called hinge which links the S domain to the protruding (P) 
domain that correspond to C-terminal region and is exposed on the virion surface 
[166, 172–174]. The hinge allows P and S domains a certain grade of flexibility on 
their tridimensional disposition [165]. The P domain contains determinants for 
virus-host receptor interactions and antigenic diversity [165, 166]. In addition, this 
region can be further subdivided into the subdomains P1 and P2, P2 contains the 
hypervariable region of the protein which allows for the selection of variants that 
can escape immune detection or antibody neutralization.
The marked antigenic differences observed between RHDV GI.1 and RHDV 
GI.2 [168], explain the lack of efficient protection against RHDV GI.2 afforded by 
RHDV GI.1 inactivated vaccines [91, 92], as well as, the capacity of RHDV GI.2 to 
overcome immunity derived from natural infections with RHDV GI.1 [101]. Since 
the emergence of RHDV GI.2 the development of diagnostic tools has been a very 
important issue and different techniques and methodologies have been improved 
for specific detection of RHDV GI.2 [168, 175–177].
3.6 Evolution: genotypes, antigenic variants
Although perceived as a novel virus (GI.1) in the initial 1984 outbreak, retro-
spective serological analysis [108] and sequence analysis [178–181] have cast doubt 
on this assumption. Molecular clock analysis suggest the virus emerged before it 
was officially detected [182]. These studies back the theory that RHDV or similar 
viruses existed in less virulent forms or went unnoticed and were circulating in the 
rabbit population long before the emergence of RHDV as a major concern [183]. 
Whether GI.1 and GI.2 arose from non-pathogenic viruses, through recombination 
events, or through species jumps remains to be determined [184–186].
Genetic diversity among pathogenic RHDV isolates has been the subject of 
intense study with the capsid protein (partial or complete) being the main target. 
Recent advances in sequencing techniques has allowed full genome analysis in 
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retrospective studies and demonstrate the importance of analysing complete 
genomes [187, 188].
Studies on the evolution of RHDV GI.1 in Europe showed low levels of sequence 
variation [183, 189] in the years following its emergence although it was possible 
to define distinct phylogenetic groups. In the 12 years following the emergence 
of RHDV GI.1 in France six genogroups were identified [190, 191] (now termed 
GI.1a-d). Genogroup 6 or RHDVa (GI.1a) is an antigenic variant first isolated in 
Italy [192]. Although antigenically distinct with a sequence similarity in the VP60 
gene of 93%, GI.1 based vaccines provided protection against this highly pathogenic 
virus [191, 192].
The evolution of RHDV has followed a different trend in Spain compared to the 
rest of Europe. Only GI.1d strains (previously genogroup 1) have been detected in 
samples collected between 1988 and 2010. This may be due to a smaller number of 
samples being analysed, however, unlike in the rest of Europe, GI.1 strains were still 
being detected in the Iberian Peninsula in 2010. RHDVa was detected once in Spain 
in domestic rabbits [193] but does not appear to have been widespread and has not 
been detected in wild rabbits. In Australia the Czech strain V-351 (an RHDV GI.1) 
escaped from testing facilities in 1995. The sequence of virus circulating in Australia 
changed little in the first years following its escape [194], however, the study of 
RHDV sequences spanning the subsequent 16 years revealed its evolutionary ten-
dency on this continent. Although subject of more than 3500 independent releases 
during this time, positive selection suggested the evolution of strains capable out-
competing freshly released strains and spreading in the presence of non-pathogenic 
rabbit calicivirus (RCV)-A1 (also GI.4a) [195]. In order to more effectively compete 
against the presence of RCV-A1, the antigenic variant RHDVa-K5 (GI.1a-K5) was 
released in 2014. Australian RHDV GI.1 strains gained virulence reflecting the 
selection of viruses [196] based on effective transmission, the immunological status 
of existing population, landscape and weather amongst others.
Phylogenetic analysis suggested that RHDV GI.2 is genetically distant from 
RHDV GI.1 and is more closely related to RCV apathogenic viruses [91, 92]. The 
origin of RHDV GI.2 is unclear and cannot be explained by genetic evolution from 
previously described lagoviruses or recombination of existing strains [197, 198]. 
Silverio and colleagues [197] using sequences analysis and mean substitution rates 
have estimated the presence of a common ancestor for GI.2 just a few years prior 
to its first detection [197]. Experimental infections have demonstrated that RHDV 
GI.2 has gained virulence showing higher mortality rates in both adults and kittens 
[98, 199], than the strains obtained in 2011 or 2012 soon after its emergence [98, 
199]. This could indicate an evolutionary tendency of the virus, indeed, Capucci 
and colleagues (2017) [199] hypothesized that this could be similar to what 
occurred for RHDV GI.1 strains in Australia [196], RHDV GI.2 having evolved in 
their natural hosts and, since their emergence in 2010, selection pressure may have 
favoured strains with higher pathogenicity.
3.7 Recombination and lagoviruses
Recombination, along with mutation, is an important mechanism for the evolu-
tion of RNA viruses since it uses existing genetic diversity to create new genomic 
combinations. Novel RHDV virus genomes arising from natural recombination of 
existing strains have been detected in RHDV isolates [200–204]. Recent genomic 
analysis reveals that these events are more common than once envisaged [200]. and 
due to the high frequency of occurrence [195, 197, 200–203, 205] this might indicate 
an important role in their origin and emergence of pathogenicity. Indeed, Silverio 
and colleagues [197] indicated that the occurrence of recombination fits both 
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theories currently proposed for the emergence of pathogenicity in lagoviruses: (1) 
the evolution from a pre-existing non-pathogenic virus that acquired pathogenicity 
or (2) following a species jump [198]. Especially in the case of the highly frequent 
recombination events observed for the novel RHDVGI.2 and its ability to cross 
the species boundaries [99, 138, 206–208]. This also has been supported by Lopes 
and colleagues [187], who related the detection of a recombinant RHDVGI.2 in an 
Iberian hare with a species jump [187].
The number of combinations of genomes being observed is striking and reveals 
a complicated panorama. How these events shape the spread and pathogenicity of 
RHDV remains to be determined.
In recent years, recombination events in different regions of RHDV genomes 
have been identified. The existence of recombinant RHDV that contain structural 
genes from RHDV GI.1 and non-structural genes belonging to non-pathogenic 
lagovirus (GI.4) have been identified [202]. In some cases, the recombination event 
occurred inside the non-structural region [187]. Two types of RHDV GI.2 recom-
binant strains have been identified, both with their structural proteins VP60 and 
VP10 originating from GI.2, while their non-structural proteins originated from 
GI.1 or non-pathogenic strains (GI.4) [103, 187, 197].
Recombination has been reported in Iberian GI.2 genomes, with a breakpoint at 
the RdRp/VP60 boundary (Figure 4) within ORF1. This breakpoint was associated 
with several independent recombination events involving non-pathogenic strains, 
GI.1 and/or GI.2 resulting in different genomic combinations that persisted in the 
Portuguese wild rabbit populations [187, 197], and recombinant strains detected 
in Azores Islands and Australia [103, 202, 209]. The homology between the subge-
nomic RNA (encodes structural genes) and the 3′ end of the genomic RNA (encodes 
non-structural and structural genes) generates a hotspot of recombination at the 
junction between non-structural and structural genes [200, 202]. Silverio and 
colleagues [197] identified new RHDVGI.2 recombinants with a recombination 
breakpoint located near the p16-p23 (NS1/NS2) boundary (nucleotide positions 
355–471), [197]. Also, they detected the occurrence of triple recombinants con-
stituted by the NS1 non-structural protein similar to a nonpathogenic lagovirus, a 
Figure 4. 
Schematic diagram of recombinant lagovirus genomes. In the example shown recombinant Lagovirus 
europaeus/GI.1P-GI.2 indicates a recombination detected between a GI.1 and a G2 strain; P standing for 
polymerase.
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GI.1b backbone for the remaining non-structural proteins and GI.2 as the donor for 
the structural protein. Mutations in NS1 sequences has been implicated as a factor 
in increased virulence of GI.1 isolates [196].
3.8 Cross species infections of lagoviruses in lagomorphs
Prior to the emergence of RHDV GI.2, lagoviruses were considered species 
specific, RHDV was specific to the European rabbit and EBHSV was specific to the 
European brown hare [126]. However, increasing numbers of RHDVGI.2 infections 
in different species of rabbits and hares have been reported casting doubt on this 
clear differentiation. Initially considered as transient spill-over events, more wide-
spread infections of GI.2 in a number of hare species have raised concerns that this 
virus has an ampler species tropism. The first detection occurred in 7 Cape hares 
(Lepus capensis var. mediterraneus) with lesions consistent with those observed in 
RHD infections [99]. This study demonstrated for the first time that a Lepus species 
showed susceptibility to RHDV GI.2 and a clear difference with regards to suscep-
tibility to RHDV GI.1 in this species given that RHDV GI.1 had previously been 
endemic in rabbits in the same geographical area for 20 years [99]. Subsequently 
RHDV GI.2 was determined as the cause of death of a captive Italian hare (Lepus 
corsicanus). In this species virulence was more limited, only infecting a single hare 
on the compound [206]. Velarde et al. [138] described the first infections of RHDV 
GI.2 in wild European brown hares (Lepus europaeus) detected in Italy (n=1) and 
Spain (n = 2). Serological data from wild hares presented in this study reinforced 
the finding that these were sporadic infections. However, widespread infections 
detected in France [210] showed that European brown hare infected with RHDV 
GI.2 were common in areas that hares and rabbits live sympatrically. Detection of 
GI.2 related mortalities in European brown hares in Australia [211], England [212] 
and Scotland [213] demonstrate that the problem is recurrent. An outbreak in 
Germany in captive mountain hares (Lepus timidus) adds to the list of susceptible 
species and demonstrated that juvenile mountain hares could succumb to the 
disease [214]. Reports of substantial outbreaks in the absence of local rabbit popu-
lations in Sweden demonstrate potential hare-to-hare transmission of RHDV GI.2 
[215]. Wide spread deaths in different lagomorph species have also been reported 
from across the USA ([216] and news article therein) including black-tailed jack-
rabbit (Lepus californicus) and desert cottontail rabbits (Sylvilagus audubonii) [217]. 
Therefore, RHDV GI.2 exhibits a broader host range than classical RHDV (GI.1) 
by infecting not only different rabbit species but also different hare species (Lepus 
capensis mediterraneus, Lepus corsicanus, Lepus europaeus, and Lepus timidus).
Different species of hare infected by RHDV GI.2, showed very similar clini-
cal signs typical of European brown hare syndrome (EBHS): hyperaemic trachea 
sometimes containing uncoagulated blood, hepatitis necrosis, splenomegaly and 
congestion of other organs and tissues [99, 138, 206, 215].
Retrospective studies have also blurred the line defining species susceptibility to 
RHDV and EBHSV. Lopes and colleagues [218], identified the presence of RHDV in 
archival samples from Iberian hares found dead in the 1990s in Portugal with signs 
of an EBHS-like disease [218]. These authors demonstrated that RHDV GI.1 strains 
in these two cases were phylogenetically closely related to those circulating at that 
time and in the same areas in rabbit populations. These results would support the 
theory of that virus dissemination and high infection pressure in the environment 
could favour spillover events of infection of European brown hares with RHDV GI.2 
[99, 206, 210, 211].
Analysis of RHDV GI.2 positive hares sampled in 2013 [210] have shown the 
existence of co-infection by EBHSV GII.1 and RHDV GI.2. This is an important 
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issue in epidemiology and evolution, especially the potential emergence of recom-
binant EBHSV/RHDV GI.2 strains.
Species susceptibility to lagoviruses may be variable and this may reflect dif-
ferent species-specific host factors such as glycan expression for viral attachment 
[170]. With respect to this, several studies indicate that, as for noroviruses [219], 
specific binding between lagoviruses and glycans, particularly those of the HBGAs 
found in the upper respiratory tract and intestines of rabbits, is the first step of 
the viral infection [169, 220, 221]. Rabbits have different types of HBGAs and 
different virus strains show variable affinity to these molecules. Subtle changes in 
those attachment factors, e.g. through mutations, cause individual animals or even 
complete species can become more or less susceptible to the virus [169, 222, 223]. 
So, a possible explanation for overcoming species barriers could be the genetic 
variation of the capsid protein VP60 which alters the binding to histo-blood group 
antigens [223] that are considered as being important entry points for the virus 
[169, 221]. Other factors that could affect RHDV GI.2 infection in different species, 
such as concurrent subclinical infections, parasitic infestations, malnutrition or 
habitat detriment [138].
4. Viruses that infect lagomorphs Part II
A major concern regarding animal viruses are zoonotic infections. While viral 
zoonosis from rabbits or hares have not been commonly documented both, rabbits 
and hares are susceptible to infections that can infect humans including rabies, 
hepatitis E virus and herpes. Rabbit susceptibility to rabies was used to great benefit 
when Louis Pasteur endeavoured to create a rabies vaccine in the 1890s. Although 
susceptible to fatal rabies infection, rabbits are a spillover host. The most commonly 
documented source of infection in rabbits is from racoons, therefore the disease 
should be considered in areas where racoon rabies is endemic.
4.1 Hepatitis E virus
Hepatitis E virus has been detected in domestic and wild rabbits and the European 
brown hare in Europe and Asia, raising concerns as to whether lagomorphs maybe a 
reservoir for human infections [224, 225]. Although a recent study did not detect the 
presence of HEV in wild lagomorphs in Spain [226]. HEV belongs to the Hepeviridae 
virus family and has a non-segmented RNA genome comprising 3 ORFs. There are 4 
genotypes, genotypes 1 and 2 cause human infections while genotpyes 3 and 4 affect 
wildlife species. Rabbit HEV is genotype 3. Liver or bile are the target organ for diag-
nosis using RT-PCR used to detect virus genome and specific ELISA to detect antibod-
ies in sera. This pathogen should be considered when handling wild lagomorphs.
4.2 Herpes virus
Humans have been cited as the source of herpes virus infection in pet rabbits. 
With a fatal outcome the infections were the result of contact with a human with a 
cold sore lesion. Post-mortem analysis revealed HSV infection [227].
Naturally occurring herpes virus infections of lagomorphs have been detected 
in rabbit and hare species, as outlined in Chapter 1 of this book. Five putative 
species of Leporid herpesvirus have been described to date. Leporid herpesvirus 
types 1 and 3 have been isolated from Sylvilagus floridanus [228, 229] and Leporid 
herpesvirus types 2 and 4 have been isolated from Oryctolagus cuniculus [228–230]. 
Recently, during an outbreak of myxomatosis in the Iberian hare (Lepus granatesis) 
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leporid herpes virus 5 was reported [73, 231]. The most studied LeHV infection is 
caused by LeHV-3 which causes tumor-like lesions in various organs such as liver, 
spleen kidney and on lymph nodes [232]. The genome sequence of LeHV-4 has 
been published [233], this virus caused systemic illness that began with acute ocular 
infections in domestic rabbits [230]. LeHV-4 has been classified as a member of 
the Alphavirus virinae subfamily, genus Simplexvirus. While LeHV1–3 are related to 
members of the Rhadinovirus genus in the Gammaherpes virinae they have not been 
approved as species (ICTV 2019 release). It has been suggested that LeHV-5 is also a 
gammaherpes virus [73, 231].
4.3 Rabbit papillomavirus
There are two species of the papillomavirus that infect lagomorphs. The first, 
previously termed Rabbit Papillomavirus (Shope papilloma virus or cottontail 
rabbit papilloma virus), predominantly infects the cottontail rabbit (Sylvilagus flori-
danus) but may also infect Oryctolagus cuniculus. The virus is now termed Sylvilagus 
floridanus papilloma virus 1 and belongs to the Kappapapillomavirus genus (Van 
Doorslaer et al.) in the family Papillomaviridae. The virus replicates in skin tissue 
causing the growth of warts on the head and neck of rabbits which can become so 
large that they appear to be horns and can impede animal feeding if growth occurs 
close to the mouth. It was the first virus to be shown to cause cancer and up to 70% 
of warts will lead to cancerous growths. Vaccines have been developed for use in 
endemic regions and the virus/rabbit infection model has served as an excellent 
animal model for the study of antivirals and vaccines. Thanks to such studies much 
is known about the molecular biology of this virus. The Kappapapillomavirus genus 
also contains a second species of virus named Oryctolagus cuniculus papilloma virus 
1. Infection of domestic rabbits with this virus causes self-limiting oral warts or 
papillomas that regress without treatment. Hares have also been reported to be 
susceptible to papillomatosis [234].
Several viruses have been implicated as contributing factors in rabbit enteritis 
complex (REC; also referred to as enterocolitis or enteritis complex). REC is a 
complex disease of the intestine in predominantly young rabbits although the 
precise causes are not known it is a multifactorial disease in which bacteria, virus, 
parasites and environmental factors are known to be important. The presence of 
several RNA viruses of notable concern has recently been analysed in this regard. 
Rotavirus, coronavirus, astrovirus and hepatitis E virus all cause enteric disease and 
may potentially be of concern [235].
4.4 Rabbit rotavirus
Rotaviruses are an important group of segmented-genome double-stranded 
RNA viruses of the family Reoviridae that cause gasterentroitis in mammals. Rabbit 
or Lapine rotavirus is a group A rotavirus and have been detected in several coun-
tries. Rabbit rotavirus infection has been implicated as a factor in “multifactorial 
enteropathy” [236]. In Spanish rabbitries, rabbit rotaviruses have been detected 
and found to often be associated with other pathogens such as Eimeria spp., C. 
spiroforme, C. perfringens, E. coli or combinations of these agents. The authors 
hypothesized that damage caused by rotavirus replication in the mucosa led to a 
predisposition for bacterial growth and infection [237]. Predominantly found in 
young farmed rabbits rotaviruses have also been described in Eastern cottontail rab-
bits (S. floridanus) and hares (Snowshoe and European hares). Molecular charac-
terisation of lapine rotavirus strains requires RT-PCR analysis with regions of the 
VP4, VP6 and VP7 genes being targets. Several genotypes exist due to the capacity 
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for reassortment and genetic mutation that these segmented RNA viruses have. 
Detection of rabbit rotavirus in human infants have been reported [238, 239].
4.5 Rabbit coronavirus
Rabbit coronavirus was first described in 1961 following electron microscope 
detection of coronavirus particles and heart was described as the target organ 
[240]. Subsequently immunoelectron microscopy was used to detect Rabbit enteric 
coronavirus and virus was isolated [241]. Rabbit enteric CoV was detected in fecal 
matter during wet market surveillance in China. The characterisation of RbCoV 
provided the complete genome sequence (RbCoV HKU14-1 genbank accession 
number JN874559) has shown it to be a Betacoronavirus and reported cases detect 
RbCoV has also been implicated as a factor in REC. RT-PCR and RT-qPCR have been 
developed targeting the RdRp gene.
During the current SARS-CoV2 pandemic the potential for infection of animal 
hosts and the establishment of reservoirs has been of great concern. Molecular 
modelling studies suggest that the rabbit ACE2 molecule shares structural similari-
ties with human ACE2 and could therefore act as a receptor for SARS-CoV2 virus 
entry leading to speculation that rabbit may be susceptible to infection [242]. 
Laboratory rabbits inoculated under experimental conditions with SARS-CoV2 
were asymptomatic and low levels of infectious virus was recovered from nasal 
swabs up to 7 days post infection [243]. Such findings emphasize the need for strict 
biosafety control measures on domestic rabbit farms. At the time of writing no 
naturally occurring cases of SARS-CoV2 have been reported in rabbits.
4.6 Rabbit astrovirus
Astroviruses (family Astroviridae) are nonenveloped, with a single-stranded 
positive sense RNA genome. The discovery of astrovirus implicated in REC multi-
factorial disease highlighted the complexity of this disease and the need for contin-
ued surveillance [235]. Astrovirus was detected in healthy and symptomatic animals 
and the precise role of this virus in rabbit disease remains to be fully explored [235]. 
The qRT-PCR designed in this study targets the ORF1b (RNA-dependent RNA poly-
merase) region and provides the necessary tools for surveillance and phylogenetic 
analysis. Virochip coupled with metagenomic analysis allowed the identification 
and determination of the first full genome sequence of this agent associated with an 
outbreak of enterocolitis in domestic rabbits in the USA [244].
Metagenomic virome studies have shown the presence of astrovirus in rabbits from 
Australia and highlighted the potential for spread by insect vectors [245]. However, 
more analysis is required to determine the pathogenesis of this virus in rabbits.
Virome studies have also identified novel lagomorph bocaparvoviruses (genome 
sequence genbank accession number NC_028973) [246], picornavirus, calicivi-
ruses amounst others [245]. The relevance of these viruses to the sanitary status of 
lagomorphs should be monitored. Such metagenomic studies offer novel insights 
into the viruses of these species and indicate the complexity of multifactorial 
conditions. The molecular tools that can be garnered will undoubtedly improve our 
understanding of the viral diseases of lagomorphs.
5. Concluding remarks
The detection of recent cross species transmissions of both MYXV and RHDV 
between lagomorph species, both sporadic and widespread and findings from the 
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analysis of historic samples are changing our view on the species susceptible to 
these diseases. Rabbit and hare species are genetically and immunologically similar 
and, in many regions, live sympatrically, key factors when considering virus species 
jumps. Soon after the release of MXYV in 1950 hares were known to be suscep-
tible to this disease, however, no large-scale infections were documented until 
2018. RHDV GI.1 emerged in 1984 in the European rabbit and this was the only 
lagomorph species apparently affected until the emergence of RHDV GI.2 in 2010. 
What has driven these changes to occur is a matter for study and the effect of these 
species jumps on lagomorph populations has yet to be seen. Thanks to the great 
effort of historic surveillance studies and careful sample archiving, the molecular 
evolution of these viruses is being discovered.
Metagenomic studies have also identified novel lagomorph viruses. Through 
such studies and continued surveillance therapeutics to lesser known lagomorph 
viruses and a better understanding of animal health will ensue. We may now be 
entering a new era in the study of the viruses that infect lagomorphs which will 
further our understanding on the complexity of virus-host relationship.
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